SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2025-12-17 13:35Core Viewpoint - The stock of Kaili Medical (300633) has shown mixed performance with a slight increase in price, but significant outflows from major funds indicate potential concerns about investor confidence [1][2]. Group 1: Stock Performance - As of December 17, 2025, Kaili Medical's stock closed at 26.62 yuan, up 0.41% with a turnover rate of 0.48% and a trading volume of 20,600 shares, amounting to a transaction value of 54.51 million yuan [1]. - On December 17, 2025, the net outflow of major funds was 191.2 thousand yuan, accounting for 3.51% of the total transaction value, while retail investors saw a net inflow of 106.28 thousand yuan, representing 1.95% of the total [1]. Group 2: Financial Metrics - Kaili Medical's total market capitalization is 11.519 billion yuan, which is above the industry average of 10.779 billion yuan, ranking 27th out of 125 companies in the medical device sector [2]. - The company reported a net profit of 33.51 million yuan for the first three quarters of 2025, a decrease of 69.25% year-on-year, while its main revenue increased by 4.37% to 1.459 billion yuan [2]. - The gross profit margin stands at 60.36%, significantly higher than the industry average of 51.02%, while the net profit margin is only 2.3%, much lower than the industry average of 9.59% [2]. Group 3: Analyst Ratings - In the last 90 days, 15 institutions have rated Kaili Medical, with 10 giving a "buy" rating and 5 an "accumulate" rating, indicating a generally positive outlook among analysts [3]. - The average target price set by institutions over the past 90 days is 41.28 yuan, suggesting potential upside from the current trading price [3].